DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

2.33 -0.10 (-4.12%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $2.33 -4.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.43
Previous Close $2.43
Daily Range $2.29 - $2.44
52-Week Range $0.78 - $3.33
Market Cap $412.6M
P/E Ratio -6.75
Dividend (Yield) $0.00 (0.0%)
Volume 3,027,510
Average Daily Volume 7,785,080
Current FY EPS -$0.40




Drug Makers

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary Rss Feed

Here's the Lowdown on Amarin Corporation PLCs 55% Move Higher in March

Small-cap biotech stock Amarin was cleared for takeoff in March on the heels of positive commentary from Wall Street and a better-than-expected earnings report. Find out if shares can rally even higher.

Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine

With Shares Down But Prescriptions Up, It's Time To Accumulate Amarin

Benzinga's Top #PreMarket Losers

Amarin's Constellation Of Possibilities Defy The Fall Of Night

How Amarin Corporation (AMRN) Stock Stands Out in a Strong Industry - Tale of the Tape

Amarin: Vascepa To Continue Steady Growth

These 5 Stocks Have More Than Doubled In 2015

3 Biotech Stocks in Danger of Running Out of Cash

Although running out of money is rare, these three biotech stocks could soon find their bank accounts running dangerously low on cash.

Amarin: A Look At The Recent Selloff And Negative Perceptions

See More AMRN News...

AMRN's Top Competitors

AMRN $2.33 (-4.12%)
Current stock: AMRN
JNJ $101.08 (0.62%)
Current stock: JNJ
NVS $104.28 (-1.16%)
Current stock: NVS
RHHBY $36.24 (-0.83%)
Current stock: RHHBY